Evidence exists that antidepressants may be an independent risk factor for type 2 diabetes, however causality has not been established, according to a recent study in Diabetes Care.
Formulary Watch
Latest News
All News
Advertisement
Influenza vaccination can reduce the risk of influenza-associated pneumonia hospitalizations by more than half, according to data presented at the IDWeek Meeting recently in San Francisco.
Under a priority review to help alleviate a drug shortage, FDA has approved lipid injectable emulsion, USP (Clinolipid, Baxter Healthcare) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink.
Chronic use of opioids among obese patients prior to bariatric surgery continues after bariatric surgery, and the dose. has been shown to be greater postoperatively than preoperatively, according to a recent study in the Journal of the American Medical Association.
Patients who skip filling an antibiotic prescription after hospital discharge because of high out-of-pocket costs are at increased risk of rehospitalization and cost the healthcare system substantially more in the long term, according to a study published in the October issue of the American Journal of Managed Care.
FDA approved vortioxetine (Brintellix, Takeda Pharmaceuticals and Lundbeck) to treat adults with major depressive disorder (MDD).
Under priority review, FDA approved pertuzumab (Perjeta, Genentech, a member of the Roche Group) on September 30 as part of a complete treatment regimen for patients with early stage breast cancer before surgery.
FDA warned September 27 of an increased risk of death associated with intravenous tigecycline (Tygacil) for FDA-approved and non-approved uses.
Digoxin, commonly used to treat heart conditions, was associated with a 72% higher rate of death among adults with newly diagnosed heart failure, according to a Kaiser Permanente study in the September issue of Circulation: Cardiovascular Quality and Outcomes.
In adult patients with type 2 diabetes mellitus (T2DM) who are uncontrolled on metformin and sulfonylurea, dapagliflozin can be added to help improve HbA1c and reduce fasting plasma glucose, body weight, and seated systolic blood pressure, according to results from a study presented at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain, in September.
Advertisement
A new study may set a new standard for the treatment of venous thromboembolism (VTE) with a single oral anticoagulant.
Cognitive enhancers-drugs taken to enhance concentration, memory, alertness, and moods- that are often given to patients with Alzheimer’s disease do not improve cognition or function for those with mild cognitive impairment (MCI) in the long term-about 96 weeks, according to a study published recently in the Canadian Medical Association Journal.
FDA has approved ustekinumab (Stelara, Janssen Biotech) alone or in combination with methotrexate for active psoriatic arthritis in adult patients aged 18 years and older.
A new report by the US Centers for Disease Control and Prevention (CDC) says millions of Americans are at risk from drug-resistant superbugs that cause gonorrhea, C. difficile, and carbapenem-resistant Enterobacteriaceae (CRE).
FDA is requiring color changes to the printing on fentanyl (Duragesic) pain patches so that it is clearly visible, to help avoid risk of accidental exposure. Accidental exposure to these patches that contain a narcotic opioid can cause serious harm and death in children, pets, and others.
Tamoxifen use among some women with breast cancer has been reported to cause mental “fogginess” while on the medication, and researchers have demonstrated that the side effect is real, according to an online study published Sept. 17 in the Journal of Neuroscience.
Physicians discussed sunscreen use with patients at less than 1 percent of visits, according to recent study results.
About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder (MDD) have greater difficulty quitting, according to a study published September 17 in the Annals of Internal Medicine.
FDA has approved the oral chemotherapy tablet capecitabine, the first generic version of Teva’s Xeloda, to treat cancer of the colon or rectum that has spread to other parts of the body. It also approved generic capecitabine for treatment of metastatic breast cancer.
In order to help combat the national prescription drug abuse epidemic, CVS Caremark is tapping its extensive database to identify and halt inappropriate prescribing of high-risk drugs such as opioid painkillers.
Filling a prescription at a doctor’s office may be convenient, but it’s certainly no bargain for patients or taxpayers, according to an analysis of workers’ compensation payouts in Maryland and Pennsylvania.
In hopes of decreasing opioid abuse, addictions, and overdose deaths, FDA this week announced safety-labeling changes for all extended-release and long-acting (ER/LA) opioid analgesics used to treat pain. FDA has also added new postmarket study requirements for opioids such as morphine, oxycodone, and fentanyl.
Children who miss diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine doses are at more likely to develop whooping cough, according to a study in JAMA Pediatrics.
FDA expanded the approved uses of paclitaxel protein-bound particles for injectable suspension, albumin-bound (Abraxane, Celgene) to treat patients with metastatic pancreatic cancer.
In an effort to help facilitate accurate and uniform records of US vaccine usage, the Centers for Disease Control and Prevention (CDC) and immunization community stakeholders are exploring the potential of 2-dimensional (2D) barcoding to streamline immunization practices.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
PBM reform. It has finally happened
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
ACHP announces new funding to elevate patient voices in diabetes research
4
Melanoma diagnoses projected to rise in 2026
5